Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine
- PMID: 6145359
- DOI: 10.1176/ajp.141.6.796
Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine
Abstract
Withdrawal of dopamine agonists may precipitate or exacerbate neuroleptic malignant syndrome. This case report of neuroleptic malignant syndrome following withdrawal of neuroleptics and amantadine suggests that dopamine agonists should not be discontinued in hyperpyrexic patients at risk for this syndrome.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
